SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-004472
Filing Date
2021-02-22
Accepted
2021-02-22 10:14:43
Documents
79
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1116713
2 ex4-3.htm EX-4.3 75677
3 ex4-4.htm EX-4.4 164854
4 ex10-7.htm EX-10.7 139913
5 ex31-1.htm EX-31.1 11673
6 ex31-2.htm EX-31.2 11479
7 ex32-1.htm EX-32.1 6266
8 ex32-2.htm EX-32.2 6203
9 image_001.jpg GRAPHIC 4163
  Complete submission text file 0001493152-21-004472.txt   8579180

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE taug-20201231.xml EX-101.INS 1462064
11 XBRL SCHEMA FILE taug-20201231.xsd EX-101.SCH 92443
12 XBRL CALCULATION FILE taug-20201231_cal.xml EX-101.CAL 68406
13 XBRL DEFINITION FILE taug-20201231_def.xml EX-101.DEF 355624
14 XBRL LABEL FILE taug-20201231_lab.xml EX-101.LAB 598572
15 XBRL PRESENTATION FILE taug-20201231_pre.xml EX-101.PRE 445985
Mailing Address 4 NANCY COURT, SUITE 4 WAPPINGERS FALLS NY 12590
Business Address 4 NANCY COURT, SUITE 4 WAPPINGERS FALLS NY 12590 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53723 | Film No.: 21658633
SIC: 2833 Medicinal Chemicals & Botanical Products